TG Therapeutics Inc (NASDAQ:TGTX)

5.16
Delayed Data
As of May 27
 +0.11 / +2.18%
Today’s Change
4.73
Today|||52-Week Range
41.00
-72.84%
Year-to-Date
Time to Weed Your Holdings and Upgrade Your Portfolio
May 23 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close5.05
Today’s open5.01
Day’s range4.77 - 5.25
Volume335,250
Average volume (3 months)2,744,071
Market cap$778.5M
Data as of 4:00pm ET, 05/27/2022

Growth & Valuation

Earnings growth (last year)-8.68%
Earnings growth (this year)+23.19%
Earnings growth (next 5 years)-57.11%
Revenue growth (last year)+4,300.66%
P/E ratioNM
Price/Sales375.58
Price/Book3.26

Competitors

 Today’s
change
Today’s
% change
CPRXCatalyst Pharmaceuti...+0.31+4.42%
PAHCPhibro Animal Health...+0.49+2.58%
TBPHTheravance Biopharma...+0.32+3.59%
MIRMMirum Pharmaceutical...+0.24+0.98%
Data as of 4:00pm ET, 05/27/2022

Financials

Next reporting dateMay 30, 2022
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$6.7M
Annual profit (last year)-$348.1M
Net profit margin-5,204.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts